1 – 2 of 2 jobs
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
At SCALEUP.house - in the past 90 days, weve automated client reporting workflows, built live BI dashboards for scale-up founders, and developed AI-driven market research pipelines. Now we need someone to help us do more of
